Prevalence of Ocular Surface Disease in Glaucoma Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients 18 years or older with open-angle glaucoma or ocular hypertension were consecutively recruited for the study.
Diagnosis of glaucoma;
Other protocol-defined inclusion criteria may apply.
Inability to understand trial procedures;
Inability to understand Informed Consent;
Current use or use within the last 3 months of Restasis, steroids, or topical ocular non-steroidal anti-inflammatory drugs;
Previous glaucoma, corneal, or conjunctival surgery;
Other protocol-defined exclusion criteria may apply.